Shaanxi BLOOM Tech Co., Ltd. is one of the most experienced manufacturers and suppliers of compound febantel tablets in China. Welcome to wholesale bulk high quality compound febantel tablets for sale here from our factory. Good service and reasonable price are available.
Compound Febantel Tablets is a broad-spectrum, highly effective compound anthelmintic formulation. Its core ingredient, febantel, is a benzimidazole prodrug that metabolizes in vivo into the biologically active compounds fenbendazole (fenbendazole sulfoxide) and ofendazole. irreversibly inhibiting β-tubulin polymerization within parasite cells. This disrupts their energy metabolism and cellular structure, ultimately causing parasite death. This combination formulation is typically co-formulated with praziquantel, an anthelmintic with a distinct mechanism of action. Praziquantel induces increased calcium ion permeability in parasite cell membranes, causing tonic-clonic contractions in parasite muscles and epidermal damage, thereby rendering them vulnerable to host immune system attacks. This dual-mechanism design achieves multi-target elimination of internal parasites, demonstrating exceptional combined efficacy against gastrointestinal nematodes (e.g., roundworms, hookworms, whipworms) common in dogs and cats, tapeworms, and certain flukes. This approach not only broadens the spectrum of parasitic control and enhances efficacy but also helps delay the development of parasite resistance. As such, it stands as a crucial veterinary medication for the prevention and treatment of mixed parasitic infections.
|
|
|
Febantel Powder COA
Drug Overview: Scientific Design of Compound Formulations
Compound Febantel Tablets (a broad-spectrum deworming drug commonly used in veterinary clinical practice) is designed based on the core concept of achieving dual coverage of canine roundworms and tapeworms through the synergistic action of three active ingredients. This compound formulation not only expands the deworming spectrum but also significantly enhances treatment efficiency and reduces the risk of drug resistance by targeting multiple aspects of the parasites' survival systems.
The Synergistic Mechanism of the Compound Components
The compound Febantel Tablets consist of Febantel, Praziquantel, and Pyrantel Pamoate. The three components exert their effects through different mechanisms together:
Non-bantel metabolic activation
Non-bantel belongs to the pre-benzimidazole class of drugs. After oral administration, it is rapidly absorbed by the gastrointestinal tract and is transformed into fenbendazole and oxfendazole by the action of the liver and intestinal microorganisms. These two metabolites inhibit the polymerization of parasite microtubules, block glucose uptake and energy metabolism, ultimately leading to the death of the parasites. For example, fenbendazole has a killing rate of over 98% against adult whipworms, and it also has a significant inhibitory effect on egg stages.
Surface destruction of praziquantel
Praziquantel is a pyrazine isoquinoline derivative. It is almost completely absorbed after oral administration, and its blood concentration peaks within 2.5 hours. It activates the calcium ion channels on the parasite's surface, causing muscle tetanic contractions and rapid expulsion of focal vacuoles, resulting in the rupture and paralysis of the parasite's surface. This mechanism is effective against both adult and larval tapeworms, especially showing a prominent killing effect on Echinococcus tapeworms, capable of eliminating over 95% of the adult and larval forms.
Neuroparalysis of thiacetidine
Thiacetidine acts directly in the intestine and induces spasmodic paralysis in nematodes by mimicking the binding of acetylcholine to the nematode's choline receptor, causing them to expel feces. Due to its extremely low absorption in the intestine and very low blood concentration, it has almost no effect on the host (dog) nervous system, and is highly safe.
Advantages of the Compound Formula
Expanded spectrum of deworming
Single-component deworming drugs are often effective only against specific parasites, while the compound non-bantel tablet, through the combination of three components, covers common nematodes (such as roundworms, hookworms, and whipworms) and tapeworms (such as Echinococcus tapeworms and Dipylidium tapeworms) in dogs. For example, non-bantel has a killing rate of over 90% against nematodes, praziquantel has a clearance rate of over 95% against tapeworms, and thiacetidine has significant effects on hookworms and roundworms.
Reduced risk of drug resistance
Parasites are prone to developing resistance to single-component deworming drugs. The compound formula attacks multiple targets, reducing the possibility of parasites evading drug action through genetic mutations. For example, the metabolic products of non-bantel, fenbendazole and oxfendazole, have different mechanisms of action from thiacetidine, and can simultaneously block the energy metabolism and nerve conduction of parasites, thereby reducing the incidence of drug resistance.
Improved treatment efficiency
The compound formula can achieve "one-time administration, multiple protections", avoiding the complexity of multiple administrations or combination therapy required by single-component drugs. For example, in the treatment of canine reoccurant tapeworm infection, the compound non-bantel tablet can eliminate adult and larval forms in a single administration, while single-component fenbendazole may require repeated administration to achieve the same effect.
Clinical Application and Safety
The compound febantel tablets have been verified through multiple clinical studies for its efficacy and safety. For example, a study on canine hookworm infection showed that the number of worm eggs decreased by 99.2% 7 days after administration, and no serious adverse reactions were reported. Another study on feline roundworm infection indicated that the clearance rate of the compound non-bantel tablet was significantly higher than that of single-component fenbendazole.
In terms of safety, the incidence of side effects for Compound Fenbendazole Tablets is relatively low. Common reactions include mild vomiting, diarrhea or decreased appetite, which usually resolve on their own within 24 hours after administration. However, it is important to avoid using in combination with piperazine or cholinergic drugs to prevent drug interactions that may lead to reduced efficacy or increased toxicity. Additionally, the use of this product during pregnancy should be under the guidance of a veterinarian to avoid potential risks.
Core Medication Principles: Precise Dosage and Single Administration
Compound Fentanyl Tablets adhere to the core principle of weight-based dosing, with a standard dose of 1 tablet per 10kg of body weight (each tablet contains 150mg fentanyl, 50mg phenytoin, and 144mg dihydroxy-naphthoquinone thiazide). For example, a 20kg dog requires 2 tablets, while a 5kg puppy needs only half a tablet. This formulation ensures synergistic coverage across the parasite life cycle: Fentazol metabolites (fenbendazole, ofendazole) disrupt nematode energy metabolism; praziquantel rapidly kills tapeworms by disrupting calcium channels in their cuticle; and thiabendazole directly paralyzes nematode neuromuscular systems. This triple combination achieves single-dose clearance of both adult and immature parasites, eliminating the need for repeated treatments.
Administration Methods: Flexible Handling and Safety Monitoring
Oral Administration Techniques
Direct Feeding: Place the tablet at the base of the dog's tongue, gently close the mouth, and stroke the throat to induce swallowing. Suitable for cooperative dogs.
Food-Masked Administration: Mix the tablet with a small amount of wet food or cheese to mask the taste. Avoid administering with high-fat foods to prevent reduced absorption efficiency of fenbendazole.
Forced Administration: For refractory dogs, use a pet pill feeder to push the tablet deep into the esophagus. Monitor for vomiting post-administration.
Post-Administration Monitoring
Observe for vomiting or regurgitation within 30 minutes. If the tablet is expelled, administer a replacement dose.
Record defecation patterns. Typical signs include expulsion of dead worms or egg fragments within 24-48 hours post-administration.
Treatment Schedule: Optimized Design Based on Parasite Life Cycles
Routine Treatment
Single Dose: Suitable for nematode infections (e.g., roundworms, hookworms, whipworms) and adult tapeworm infections. The active ingredient simultaneously eliminates parasites at all developmental stages within the intestine.
Repeat Dosage: For tapeworm cysticerci or hookworm latent infections, repeat dosing is recommended 3-4 weeks after the initial treatment. For example, the shedding cycle of Echinococcus multilocularis proglottids is 21-28 days; repeat dosing covers newly infected larvae.
Special Use Scenarios
Pregnant Dogs: May be administered during mid-to-late pregnancy (after 4 weeks) under veterinary supervision, but dosage must be strictly adjusted by weight to avoid overdose and miscarriage risk.
Puppies: Suitable for puppies ≥3 weeks old and weighing ≥0.9kg, but requires divided dosing (e.g., crushing tablets and mixing proportionally with food).
Contraindications and Precautions: Key Risk Mitigation Points
Drug Interactions
Antagonism: Do not co-administer with piperazine compounds (e.g., piperazine phosphate), as piperazine reverses thiabendazole's paralytic effect on nematodes, reducing efficacy.
Synergistic Toxicity: Avoid concurrent administration with cholinesterase inhibitors (e.g., neostigmine) or organophosphate drugs, as this may induce cholinergic crisis (salivation, diarrhea, respiratory distress).
Adverse Reaction Management
Common Reactions: Approximately 5%-10% of dogs may experience mild vomiting or decreased appetite, typically resolving spontaneously within 24 hours.
Severe Reactions: Overdose (e.g., >30mg/kg) may cause neurological symptoms (tremors, convulsions) or liver dysfunction (elevated ALT). Immediately discontinue medication and seek veterinary care.
Storage and Disposal
Store in a sealed container, protected from light and moisture. Shelf life is typically 36 months.
Expired or unused tablets must be disposed of through veterinary clinics or designated drug collection points to prevent environmental contamination.
Clinical Application Cases: Translating Theory into Practice
Mixed Infection Treatment
A 30kg German Shepherd co-infected with Toxocara canis and Dipylidium caninum received 3 tablets based on body weight. Dead adult roundworms and tapeworm segments were detected in feces on Day 3. Follow-up fecal examination on Day 7 was negative, with no adverse reactions throughout treatment.
Drug Resistance Management
A kennel experiencing rising hookworm resistance due to prolonged use of single-ingredient dewormers switched to compound febantel t
ablets. Hookworm clearance rates increased from 68% to 95%, with no recurrence within six months.
Case One
In a clinical case, a one-year-old Labrador dog was brought to the hospital due to persistent lethargy, emaciation, intermittent diarrhea, and the presence of suspected tapeworm segments in its feces. After the veterinarian conducted flotation and sedimentation microscopic examinations of the feces, it was diagnosed with a mixed parasitic infection. The eggs of Toxocara canis and Ancylostoma caninum were detected, and at the same time, based on the clinical symptoms and the morphology of the segments, there was a high suspicion of tapeworm (Dipylidium caninum) infection. Given this complex infection situation, the veterinarian decided to prescribe Compound Febantel Tablets for deworming treatment. The core advantage of this compound formulation lies in its dual synergistic mechanism: Febantel, as a precursor drug, is metabolized in the body to form fenbenzadazole and its sulfoxide and other active components. They can specifically and irreversibly bind to the β-tubulin of the parasite's intestinal cells, inhibiting their aggregation, thereby disrupting the energy metabolism and cell transportation system of the parasite, causing efficient killing of both larval and adult worms; at the same time, the praziquantel in the formula has a unique effect on tapeworms and flukes. It can rapidly penetrate the parasite's epidermis, increase the permeability of the cell membrane to calcium ions, trigger intense muscle spastic contractions and vacuolation of the epidermis, causing the parasite to detach from the intestinal wall and subsequently disintegrate and digest. Within 24 hours after administration, the affected dog only experienced a brief and mild drowsiness and decreased appetite, without any other serious adverse reactions. After a week of re-examination, the fecal worm eggs turned negative, and the tapeworm segments completely disappeared; after a two-week follow-up, the dog's appetite and weight had significantly recovered, the diarrhea symptoms had disappeared, and the spirit was lively. This indicates that this treatment not only successfully cleared multiple adult and larval worms and larvae of the mixed infection, effectively blocking the parasite's life cycle, but also significantly improved the overall health condition of the animal, fully demonstrating the broad-spectrum, high-efficiency, and safe clinical value of this compound drug, and is a classic solution for managing complex internal parasitic infections in dogs and cats.
Hot Tags: compound febantel tablets, suppliers, manufacturers, factory, wholesale, buy, price, bulk, for sale